DE69407561T2 - Harnstoff Derivate und deren Verwendung als ACAT Inhibitoren - Google Patents
Harnstoff Derivate und deren Verwendung als ACAT InhibitorenInfo
- Publication number
- DE69407561T2 DE69407561T2 DE69407561T DE69407561T DE69407561T2 DE 69407561 T2 DE69407561 T2 DE 69407561T2 DE 69407561 T DE69407561 T DE 69407561T DE 69407561 T DE69407561 T DE 69407561T DE 69407561 T2 DE69407561 T2 DE 69407561T2
- Authority
- DE
- Germany
- Prior art keywords
- group
- alkyl
- formula
- butyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003112 inhibitor Substances 0.000 title claims description 3
- 150000003672 ureas Chemical class 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 claims description 141
- -1 benzylpiperidyl group Chemical group 0.000 claims description 47
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 25
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 20
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 8
- 125000002350 geranyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 8
- 201000001320 Atherosclerosis Diseases 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 6
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 5
- 101100294106 Caenorhabditis elegans nhr-3 gene Proteins 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 125000005936 piperidyl group Chemical group 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims description 3
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims description 3
- 208000035150 Hypercholesterolemia Diseases 0.000 claims description 3
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims description 3
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical group C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 claims description 3
- 238000011321 prophylaxis Methods 0.000 claims description 3
- 238000011282 treatment Methods 0.000 claims description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 125000004193 piperazinyl group Chemical group 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 3
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 claims 1
- PPNCOQHHSGMKGI-UHFFFAOYSA-N 1-cyclononyldiazonane Chemical group C1CCCCCCCC1N1NCCCCCCC1 PPNCOQHHSGMKGI-UHFFFAOYSA-N 0.000 claims 1
- 125000006267 biphenyl group Chemical group 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 126
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 81
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 80
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 75
- 239000002904 solvent Substances 0.000 description 61
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 57
- 239000000203 mixture Substances 0.000 description 55
- 239000000243 solution Substances 0.000 description 48
- 238000005160 1H NMR spectroscopy Methods 0.000 description 44
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 40
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 39
- 238000002844 melting Methods 0.000 description 36
- 230000008018 melting Effects 0.000 description 36
- 238000000034 method Methods 0.000 description 35
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 34
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 33
- 238000001816 cooling Methods 0.000 description 31
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 30
- 238000010898 silica gel chromatography Methods 0.000 description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- 239000003960 organic solvent Substances 0.000 description 25
- 239000013078 crystal Substances 0.000 description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 20
- 235000019441 ethanol Nutrition 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 239000002253 acid Substances 0.000 description 18
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 17
- 235000019341 magnesium sulphate Nutrition 0.000 description 17
- 235000012000 cholesterol Nutrition 0.000 description 16
- 230000002401 inhibitory effect Effects 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- NISGSNTVMOOSJQ-UHFFFAOYSA-N cyclopentanamine Chemical compound NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 15
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 15
- 102000007330 LDL Lipoproteins Human genes 0.000 description 14
- 108010007622 LDL Lipoproteins Proteins 0.000 description 14
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 14
- 239000003054 catalyst Substances 0.000 description 14
- 238000001914 filtration Methods 0.000 description 14
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 14
- YEXOWHQZWLCHHD-UHFFFAOYSA-N 3,5-ditert-butyl-4-hydroxybenzoic acid Chemical compound CC(C)(C)C1=CC(C(O)=O)=CC(C(C)(C)C)=C1O YEXOWHQZWLCHHD-UHFFFAOYSA-N 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 13
- 238000002425 crystallisation Methods 0.000 description 13
- 230000008025 crystallization Effects 0.000 description 13
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 12
- 239000011230 binding agent Substances 0.000 description 12
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 12
- RFXBSYPBSRSQDU-UHFFFAOYSA-N 1-isocyanatoheptane Chemical compound CCCCCCCN=C=O RFXBSYPBSRSQDU-UHFFFAOYSA-N 0.000 description 11
- 230000003902 lesion Effects 0.000 description 11
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 230000003197 catalytic effect Effects 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000010531 catalytic reduction reaction Methods 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- 239000001257 hydrogen Substances 0.000 description 9
- 230000004048 modification Effects 0.000 description 9
- 238000012986 modification Methods 0.000 description 9
- 230000001590 oxidative effect Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000012948 isocyanate Substances 0.000 description 8
- 150000002513 isocyanates Chemical class 0.000 description 8
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 7
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 210000002540 macrophage Anatomy 0.000 description 7
- AHWALFGBDFAJAI-UHFFFAOYSA-N phenyl carbonochloridate Chemical compound ClC(=O)OC1=CC=CC=C1 AHWALFGBDFAJAI-UHFFFAOYSA-N 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 6
- 210000000497 foam cell Anatomy 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 235000002639 sodium chloride Nutrition 0.000 description 6
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 230000003143 atherosclerotic effect Effects 0.000 description 5
- 239000003638 chemical reducing agent Substances 0.000 description 5
- 229940043279 diisopropylamine Drugs 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 5
- 229910003446 platinum oxide Inorganic materials 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 235000011150 stannous chloride Nutrition 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 4
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 4
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 4
- 230000010307 cell transformation Effects 0.000 description 4
- 150000001840 cholesterol esters Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000002140 halogenating effect Effects 0.000 description 4
- 229940118019 malondialdehyde Drugs 0.000 description 4
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 4
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 239000011135 tin Substances 0.000 description 4
- 229910052718 tin Inorganic materials 0.000 description 4
- 239000008096 xylene Substances 0.000 description 4
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 3
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 3
- BSQREVGJORPQTB-UHFFFAOYSA-N 1-[4-(dimethylamino)phenyl]-3-heptyl-1-[[2-(heptylcarbamoylamino)phenyl]methyl]urea Chemical compound CCCCCCCNC(=O)NC1=CC=CC=C1CN(C(=O)NCCCCCCC)C1=CC=C(N(C)C)C=C1 BSQREVGJORPQTB-UHFFFAOYSA-N 0.000 description 3
- VBHCPGFCIQDXGZ-UHFFFAOYSA-N 1-isocyanatoadamantane Chemical compound C1C(C2)CC3CC2CC1(N=C=O)C3 VBHCPGFCIQDXGZ-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- GDSMEZNTTFTKTK-UHFFFAOYSA-N 2-amino-n-[4-(dimethylamino)phenyl]benzamide Chemical compound C1=CC(N(C)C)=CC=C1NC(=O)C1=CC=CC=C1N GDSMEZNTTFTKTK-UHFFFAOYSA-N 0.000 description 3
- PUGDHSSOXPHLPT-UHFFFAOYSA-N 4-fluoro-2-nitroaniline Chemical compound NC1=CC=C(F)C=C1[N+]([O-])=O PUGDHSSOXPHLPT-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 3
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- KUHRIIPUCPOQMQ-UHFFFAOYSA-N n,n-diethyl-3-(ethyliminomethylideneamino)propan-1-amine Chemical compound CCN=C=NCCCN(CC)CC KUHRIIPUCPOQMQ-UHFFFAOYSA-N 0.000 description 3
- AEWDSRGPUBORTN-UHFFFAOYSA-N n-(2-aminophenyl)-3,5-ditert-butyl-4-hydroxybenzamide Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(C(=O)NC=2C(=CC=CC=2)N)=C1 AEWDSRGPUBORTN-UHFFFAOYSA-N 0.000 description 3
- ZIHCJGSJNBZPJN-UHFFFAOYSA-N n-[4-(dimethylamino)phenyl]-2-(heptylcarbamoylamino)benzamide Chemical compound CCCCCCCNC(=O)NC1=CC=CC=C1C(=O)NC1=CC=C(N(C)C)C=C1 ZIHCJGSJNBZPJN-UHFFFAOYSA-N 0.000 description 3
- QNZMKZUXUZMHJB-SLEBQGDGSA-N n-[4-(dimethylamino)phenyl]-n-[(2e)-3,7-dimethylocta-2,6-dienyl]-2-(heptylcarbamoylamino)benzamide Chemical compound CCCCCCCNC(=O)NC1=CC=CC=C1C(=O)N(C\C=C(/C)CCC=C(C)C)C1=CC=C(N(C)C)C=C1 QNZMKZUXUZMHJB-SLEBQGDGSA-N 0.000 description 3
- LTGYRKOQQQWWAF-UHFFFAOYSA-N n-methylheptan-1-amine Chemical compound CCCCCCCNC LTGYRKOQQQWWAF-UHFFFAOYSA-N 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000001119 stannous chloride Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- PEKAFPRRAFECMG-UHFFFAOYSA-N (2-aminophenyl) 3,5-ditert-butyl-4-hydroxybenzoate Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(C(=O)OC=2C(=CC=CC=2)N)=C1 PEKAFPRRAFECMG-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- XBDVZAINWOFGIM-UHFFFAOYSA-N 1-(1-benzylpiperidin-4-yl)-3-[2-[3-(3,5-ditert-butyl-4-hydroxyphenyl)propoxy]phenyl]urea Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CCCOC=2C(=CC=CC=2)NC(=O)NC2CCN(CC=3C=CC=CC=3)CC2)=C1 XBDVZAINWOFGIM-UHFFFAOYSA-N 0.000 description 2
- YYGJNUNQIWWBGM-UHFFFAOYSA-N 1-(2-amino-4-methoxyphenyl)-3-cyclopentylurea Chemical compound NC1=CC(OC)=CC=C1NC(=O)NC1CCCC1 YYGJNUNQIWWBGM-UHFFFAOYSA-N 0.000 description 2
- LOQMQPWRVINQQX-UHFFFAOYSA-N 1-(3,4-dichlorophenyl)-3-heptylurea Chemical compound CCCCCCCNC(=O)NC1=CC=C(Cl)C(Cl)=C1 LOQMQPWRVINQQX-UHFFFAOYSA-N 0.000 description 2
- IGMLIWRJGWKQBG-UHFFFAOYSA-N 1-(3-aminopyridin-2-yl)-3-heptylurea Chemical compound CCCCCCCNC(=O)NC1=NC=CC=C1N IGMLIWRJGWKQBG-UHFFFAOYSA-N 0.000 description 2
- UKTQKHWFBOBNEP-UHFFFAOYSA-N 1-(4-aminopyridin-3-yl)-3-heptylurea Chemical compound CCCCCCCNC(=O)NC1=CN=CC=C1N UKTQKHWFBOBNEP-UHFFFAOYSA-N 0.000 description 2
- UKUZEJLSBFKZNZ-UHFFFAOYSA-N 1-(4-fluoro-2-nitrophenyl)-3-heptylurea Chemical compound CCCCCCCNC(=O)NC1=CC=C(F)C=C1[N+]([O-])=O UKUZEJLSBFKZNZ-UHFFFAOYSA-N 0.000 description 2
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 2
- JFDMEOFYLJGWLG-WEMUOSSPSA-N 1-[2-[[4-(dimethylamino)-n-[(2e)-3,7-dimethylocta-2,6-dienyl]anilino]methyl]phenyl]-3-heptylurea Chemical compound CCCCCCCNC(=O)NC1=CC=CC=C1CN(C\C=C(/C)CCC=C(C)C)C1=CC=C(N(C)C)C=C1 JFDMEOFYLJGWLG-WEMUOSSPSA-N 0.000 description 2
- UJHCUQJHCKDAAV-UHFFFAOYSA-N 1-cyclopentyl-3-(4-methoxy-2-nitrophenyl)urea Chemical compound [O-][N+](=O)C1=CC(OC)=CC=C1NC(=O)NC1CCCC1 UJHCUQJHCKDAAV-UHFFFAOYSA-N 0.000 description 2
- XRDTWBWNHDKUKB-UHFFFAOYSA-N 1-heptyl-3-(3-nitropyridin-2-yl)urea Chemical compound CCCCCCCNC(=O)NC1=NC=CC=C1[N+]([O-])=O XRDTWBWNHDKUKB-UHFFFAOYSA-N 0.000 description 2
- RRLRWANEZGPBAD-UHFFFAOYSA-N 1-phenyl-n-(pyridin-2-ylmethyl)methanamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=N1 RRLRWANEZGPBAD-UHFFFAOYSA-N 0.000 description 2
- NHSRPTLLXNICLL-UHFFFAOYSA-N 2,6-ditert-butyl-4-[3-(2-nitrophenoxy)propyl]phenol Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CCCOC=2C(=CC=CC=2)[N+]([O-])=O)=C1 NHSRPTLLXNICLL-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- FXEWVCQYQLLMJF-LVZFUZTISA-N 2-amino-n-[4-(dimethylamino)phenyl]-n-[(2e)-3,7-dimethylocta-2,6-dienyl]benzamide Chemical compound C1=CC(N(C)C)=CC=C1N(C\C=C(/C)CCC=C(C)C)C(=O)C1=CC=CC=C1N FXEWVCQYQLLMJF-LVZFUZTISA-N 0.000 description 2
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 2
- 125000005916 2-methylpentyl group Chemical group 0.000 description 2
- SLAMLWHELXOEJZ-UHFFFAOYSA-N 2-nitrobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1[N+]([O-])=O SLAMLWHELXOEJZ-UHFFFAOYSA-N 0.000 description 2
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 2
- ILPUJHFAISEGEI-UHFFFAOYSA-N 3,5-ditert-butyl-n-[2-(dibenzylcarbamoylamino)phenyl]-4-hydroxybenzamide Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(C(=O)NC=2C(=CC=CC=2)NC(=O)N(CC=2C=CC=CC=2)CC=2C=CC=CC=2)=C1 ILPUJHFAISEGEI-UHFFFAOYSA-N 0.000 description 2
- IMFLKZHTBPJOHX-UHFFFAOYSA-N 3,5-ditert-butyl-n-[2-(heptylcarbamoylamino)-4-methoxyphenyl]-4-hydroxybenzamide Chemical compound CCCCCCCNC(=O)NC1=CC(OC)=CC=C1NC(=O)C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 IMFLKZHTBPJOHX-UHFFFAOYSA-N 0.000 description 2
- PWXMAGJHGZTFBH-UHFFFAOYSA-N 3,5-ditert-butyl-n-[2-(heptylcarbamoylamino)phenyl]-4-hydroxy-n-methylbenzamide Chemical compound CCCCCCCNC(=O)NC1=CC=CC=C1N(C)C(=O)C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 PWXMAGJHGZTFBH-UHFFFAOYSA-N 0.000 description 2
- DIAYDDNCZHDLJD-UHFFFAOYSA-N 3,5-ditert-butyl-n-[2-(heptylcarbamoylamino)phenyl]-4-hydroxybenzamide Chemical compound CCCCCCCNC(=O)NC1=CC=CC=C1NC(=O)C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 DIAYDDNCZHDLJD-UHFFFAOYSA-N 0.000 description 2
- LYQQKEDCKXWWOZ-UHFFFAOYSA-N 3,5-ditert-butyl-n-[2-(heptylcarbamoylamino)pyridin-3-yl]-4-hydroxybenzamide Chemical compound CCCCCCCNC(=O)NC1=NC=CC=C1NC(=O)C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 LYQQKEDCKXWWOZ-UHFFFAOYSA-N 0.000 description 2
- MNOAJRNIFLRWDF-UHFFFAOYSA-N 3,5-ditert-butyl-n-[3-(heptylcarbamoylamino)pyridin-4-yl]-4-hydroxybenzamide Chemical compound CCCCCCCNC(=O)NC1=CN=CC=C1NC(=O)C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 MNOAJRNIFLRWDF-UHFFFAOYSA-N 0.000 description 2
- FXOGLKMLBHIZOJ-UHFFFAOYSA-N 3,5-ditert-butyl-n-[4,5-dichloro-2-(heptylcarbamoylamino)phenyl]-4-hydroxybenzamide Chemical compound CCCCCCCNC(=O)NC1=CC(Cl)=C(Cl)C=C1NC(=O)C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 FXOGLKMLBHIZOJ-UHFFFAOYSA-N 0.000 description 2
- AOLRZUXGYBZQFM-UHFFFAOYSA-N 3,5-ditert-butyl-n-[5-fluoro-2-(heptylcarbamoylamino)phenyl]-4-hydroxybenzamide Chemical compound CCCCCCCNC(=O)NC1=CC=C(F)C=C1NC(=O)C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 AOLRZUXGYBZQFM-UHFFFAOYSA-N 0.000 description 2
- ZOPLOFPEGCRSSC-UHFFFAOYSA-N 3,5-ditert-butyl-n-[5-fluoro-2-[[heptyl(methyl)carbamoyl]amino]phenyl]-4-hydroxybenzamide Chemical compound CCCCCCCN(C)C(=O)NC1=CC=C(F)C=C1NC(=O)C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 ZOPLOFPEGCRSSC-UHFFFAOYSA-N 0.000 description 2
- XSMSAIMSGQYADJ-UHFFFAOYSA-N 3-(2-amino-4-fluorophenyl)-1-heptyl-1-methylurea Chemical compound CCCCCCCN(C)C(=O)NC1=CC=C(F)C=C1N XSMSAIMSGQYADJ-UHFFFAOYSA-N 0.000 description 2
- FSGTULQLEVAYRS-UHFFFAOYSA-N 4,5-dichloro-2-nitroaniline Chemical compound NC1=CC(Cl)=C(Cl)C=C1[N+]([O-])=O FSGTULQLEVAYRS-UHFFFAOYSA-N 0.000 description 2
- GEOGYJPTXLTCLM-UHFFFAOYSA-N 4-[(2-aminoanilino)methyl]-2,6-ditert-butylphenol Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CNC=2C(=CC=CC=2)N)=C1 GEOGYJPTXLTCLM-UHFFFAOYSA-N 0.000 description 2
- QFMJFXFXQAFGBO-UHFFFAOYSA-N 4-methoxy-2-nitroaniline Chemical compound COC1=CC=C(N)C([N+]([O-])=O)=C1 QFMJFXFXQAFGBO-UHFFFAOYSA-N 0.000 description 2
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 2
- 229910015900 BF3 Inorganic materials 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- RJKBQIZPGQJJBE-UHFFFAOYSA-N [2,6-ditert-butyl-4-[[2-(heptylcarbamoylamino)phenyl]carbamoyl]phenyl] n-heptylcarbamate Chemical compound CCCCCCCNC(=O)NC1=CC=CC=C1NC(=O)C1=CC(C(C)(C)C)=C(OC(=O)NCCCCCCC)C(C(C)(C)C)=C1 RJKBQIZPGQJJBE-UHFFFAOYSA-N 0.000 description 2
- AANUDQMLTNZEBL-UHFFFAOYSA-N [2-(heptylcarbamoylamino)phenyl] 3,5-ditert-butyl-4-(heptylcarbamoyloxy)benzoate Chemical compound CCCCCCCNC(=O)NC1=CC=CC=C1OC(=O)C1=CC(C(C)(C)C)=C(OC(=O)NCCCCCCC)C(C(C)(C)C)=C1 AANUDQMLTNZEBL-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- MMEHHGPOZBEKFI-UHFFFAOYSA-N n-(2-amino-4-methoxyphenyl)-3,5-ditert-butyl-4-hydroxybenzamide Chemical compound NC1=CC(OC)=CC=C1NC(=O)C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 MMEHHGPOZBEKFI-UHFFFAOYSA-N 0.000 description 2
- JFJKBGBOCJWDHZ-UHFFFAOYSA-N n-[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]-n-[[2-(heptylcarbamoylamino)phenyl]methyl]acetamide Chemical compound CCCCCCCNC(=O)NC1=CC=CC=C1CN(C(C)=O)CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 JFJKBGBOCJWDHZ-UHFFFAOYSA-N 0.000 description 2
- IYCVYHHUEONDIV-UHFFFAOYSA-N n-[4-(dimethylamino)phenyl]-2-nitrobenzamide Chemical compound C1=CC(N(C)C)=CC=C1NC(=O)C1=CC=CC=C1[N+]([O-])=O IYCVYHHUEONDIV-UHFFFAOYSA-N 0.000 description 2
- QUOWSWBPQATBAC-LVZFUZTISA-N n-[4-(dimethylamino)phenyl]-n-[(2e)-3,7-dimethylocta-2,6-dienyl]-2-nitrobenzamide Chemical compound C1=CC(N(C)C)=CC=C1N(C\C=C(/C)CCC=C(C)C)C(=O)C1=CC=CC=C1[N+]([O-])=O QUOWSWBPQATBAC-LVZFUZTISA-N 0.000 description 2
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- ARADPRPAUKZSFO-UHFFFAOYSA-N phenyl n-(4-fluoro-2-nitrophenyl)carbamate Chemical compound [O-][N+](=O)C1=CC(F)=CC=C1NC(=O)OC1=CC=CC=C1 ARADPRPAUKZSFO-UHFFFAOYSA-N 0.000 description 2
- AVIQJJIORLWADD-UHFFFAOYSA-N phenyl n-(4-methoxy-2-nitrophenyl)carbamate Chemical compound [O-][N+](=O)C1=CC(OC)=CC=C1NC(=O)OC1=CC=CC=C1 AVIQJJIORLWADD-UHFFFAOYSA-N 0.000 description 2
- IJPIPPXCTJYMSW-UHFFFAOYSA-N phenyl n-[2-[(3,5-ditert-butyl-4-hydroxybenzoyl)amino]phenyl]carbamate Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(C(=O)NC=2C(=CC=CC=2)NC(=O)OC=2C=CC=CC=2)=C1 IJPIPPXCTJYMSW-UHFFFAOYSA-N 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- OEBRJVYUOHCCCO-UHFFFAOYSA-N (2-nitrophenyl) 3,5-ditert-butyl-4-hydroxybenzoate Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(C(=O)OC=2C(=CC=CC=2)[N+]([O-])=O)=C1 OEBRJVYUOHCCCO-UHFFFAOYSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- CYXUEZWKVTUNMB-UHFFFAOYSA-N 1-(2,4-difluorophenyl)-n-(pyridin-2-ylmethyl)methanamine Chemical compound FC1=CC(F)=CC=C1CNCC1=CC=CC=N1 CYXUEZWKVTUNMB-UHFFFAOYSA-N 0.000 description 1
- NTKPQWFJAFAWKF-UHFFFAOYSA-N 1-(2-amino-4,5-dichlorophenyl)-3-cyclopentylurea Chemical compound NC1=CC(Cl)=C(Cl)C=C1NC(=O)NC1CCCC1 NTKPQWFJAFAWKF-UHFFFAOYSA-N 0.000 description 1
- OEIACIRYCBSBFY-UHFFFAOYSA-N 1-(2-amino-4,5-dichlorophenyl)-3-heptylurea Chemical compound CCCCCCCNC(=O)NC1=CC(Cl)=C(Cl)C=C1N OEIACIRYCBSBFY-UHFFFAOYSA-N 0.000 description 1
- SIOCRAOLJRCAPV-UHFFFAOYSA-N 1-(2-amino-4-fluorophenyl)-3-cyclopentylurea Chemical compound NC1=CC(F)=CC=C1NC(=O)NC1CCCC1 SIOCRAOLJRCAPV-UHFFFAOYSA-N 0.000 description 1
- BDDOHPXOIAWLCF-UHFFFAOYSA-N 1-(2-amino-4-fluorophenyl)-3-heptylurea Chemical compound CCCCCCCNC(=O)NC1=CC=C(F)C=C1N BDDOHPXOIAWLCF-UHFFFAOYSA-N 0.000 description 1
- IZTGHUPVQXEKBF-UHFFFAOYSA-N 1-[2-[[(3,5-ditert-butyl-4-hydroxyphenyl)methylamino]methyl]phenyl]-3-heptylurea Chemical compound CCCCCCCNC(=O)NC1=CC=CC=C1CNCC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 IZTGHUPVQXEKBF-UHFFFAOYSA-N 0.000 description 1
- KRAVIKGBNJXUMK-LGUFXXKBSA-N 1-[2-[[1,3-benzodioxol-5-yl-[(2e)-3,7-dimethylocta-2,6-dienyl]amino]methyl]phenyl]-3-heptylurea Chemical compound CCCCCCCNC(=O)NC1=CC=CC=C1CN(C\C=C(/C)CCC=C(C)C)C1=CC=C(OCO2)C2=C1 KRAVIKGBNJXUMK-LGUFXXKBSA-N 0.000 description 1
- JZXKKXGMGMOLIQ-UHFFFAOYSA-N 1-[4-(dimethylamino)phenyl]-3-heptyl-1-[[2-(heptylcarbamoylamino)phenyl]methyl]urea;hydrochloride Chemical compound Cl.CCCCCCCNC(=O)NC1=CC=CC=C1CN(C(=O)NCCCCCCC)C1=CC=C(N(C)C)C=C1 JZXKKXGMGMOLIQ-UHFFFAOYSA-N 0.000 description 1
- LDPJAHGMJSINRW-UHFFFAOYSA-N 1-heptyl-3-(2-hydroxyphenyl)urea Chemical compound CCCCCCCNC(=O)NC1=CC=CC=C1O LDPJAHGMJSINRW-UHFFFAOYSA-N 0.000 description 1
- YNIREHCWMARFHM-DEDYPNTBSA-N 1-n-[(2-aminophenyl)methyl]-2-[(2e)-3,7-dimethylocta-2,6-dienyl]-1-n,4-n-dimethylbenzene-1,4-diamine Chemical compound CC(C)=CCCC(/C)=C/CC1=CC(NC)=CC=C1N(C)CC1=CC=CC=C1N YNIREHCWMARFHM-DEDYPNTBSA-N 0.000 description 1
- RMZAKJUXCNOIDR-UHFFFAOYSA-N 1-n-[(2-aminophenyl)methyl]-4-n,4-n-dimethylbenzene-1,4-diamine Chemical compound C1=CC(N(C)C)=CC=C1NCC1=CC=CC=C1N RMZAKJUXCNOIDR-UHFFFAOYSA-N 0.000 description 1
- FMDPGZJHRKDDCB-DTQAZKPQSA-N 1-n-[(2e)-3,7-dimethylocta-2,6-dienyl]-4-n,4-n-dimethylbenzene-1,4-diamine Chemical compound CN(C)C1=CC=C(NC\C=C(/C)CCC=C(C)C)C=C1 FMDPGZJHRKDDCB-DTQAZKPQSA-N 0.000 description 1
- COHYOBKZKMKMIX-UHFFFAOYSA-N 1-phenyl-n-(pyridin-3-ylmethyl)methanamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CN=C1 COHYOBKZKMKMIX-UHFFFAOYSA-N 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- 125000000579 2,2-diphenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000006507 2,4-difluorobenzyl group Chemical group [H]C1=C(F)C([H])=C(F)C(=C1[H])C([H])([H])* 0.000 description 1
- WOXFMYVTSLAQMO-UHFFFAOYSA-N 2-Pyridinemethanamine Chemical compound NCC1=CC=CC=N1 WOXFMYVTSLAQMO-UHFFFAOYSA-N 0.000 description 1
- 125000006179 2-methyl benzyl group Chemical group [H]C1=C([H])C(=C(C([H])=C1[H])C([H])([H])*)C([H])([H])[H] 0.000 description 1
- RPKCLSMBVQLWIN-UHFFFAOYSA-N 2-n-methylbenzene-1,2-diamine Chemical compound CNC1=CC=CC=C1N RPKCLSMBVQLWIN-UHFFFAOYSA-N 0.000 description 1
- 125000004924 2-naphthylethyl group Chemical group C1=C(C=CC2=CC=CC=C12)CC* 0.000 description 1
- 125000006479 2-pyridyl methyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 1
- BZQGAPWJKAYCHR-UHFFFAOYSA-N 3,3-diphenylpropanoic acid Chemical compound C=1C=CC=CC=1C(CC(=O)O)C1=CC=CC=C1 BZQGAPWJKAYCHR-UHFFFAOYSA-N 0.000 description 1
- 125000002774 3,4-dimethoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- BWOGYRFVXXXJJC-UHFFFAOYSA-N 3,5-ditert-butyl-4-hydroxy-n-(4-methoxy-2-nitrophenyl)benzamide Chemical compound [O-][N+](=O)C1=CC(OC)=CC=C1NC(=O)C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 BWOGYRFVXXXJJC-UHFFFAOYSA-N 0.000 description 1
- OSXAYBLXKISMTF-UHFFFAOYSA-N 3,5-ditert-butyl-4-hydroxy-n-[5-methoxy-2-(pyridin-2-ylmethylcarbamoylamino)phenyl]benzamide Chemical compound C=1C(C(C)(C)C)=C(O)C(C(C)(C)C)=CC=1C(=O)NC1=CC(OC)=CC=C1NC(=O)NCC1=CC=CC=N1 OSXAYBLXKISMTF-UHFFFAOYSA-N 0.000 description 1
- GDQDMCDPKRWPRC-UHFFFAOYSA-N 3,5-ditert-butyl-n-[2-(dibenzylcarbamoylamino)-5-methoxyphenyl]-4-hydroxybenzamide Chemical compound C=1C(C(C)(C)C)=C(O)C(C(C)(C)C)=CC=1C(=O)NC1=CC(OC)=CC=C1NC(=O)N(CC=1C=CC=CC=1)CC1=CC=CC=C1 GDQDMCDPKRWPRC-UHFFFAOYSA-N 0.000 description 1
- XUWBPQPPRLDFSJ-UHFFFAOYSA-N 3,5-ditert-butyl-n-[2-(heptylcarbamoylamino)-5-methoxyphenyl]-4-hydroxybenzamide Chemical compound CCCCCCCNC(=O)NC1=CC=C(OC)C=C1NC(=O)C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 XUWBPQPPRLDFSJ-UHFFFAOYSA-N 0.000 description 1
- FVCLZAGGYLNSBW-UHFFFAOYSA-N 3,5-ditert-butyl-n-[2-[(3,9-dimethyl-3,9-diazabicyclo[3.3.1]nonan-7-yl)carbamoylamino]-5-methoxyphenyl]-4-hydroxybenzamide Chemical compound C=1C(OC)=CC=C(NC(=O)NC2CC3CN(C)CC(N3C)C2)C=1NC(=O)C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 FVCLZAGGYLNSBW-UHFFFAOYSA-N 0.000 description 1
- PNKMZHKBCSIKMR-UHFFFAOYSA-N 3,5-ditert-butyl-n-[2-[[(2,4-difluorophenyl)methyl-(pyridin-2-ylmethyl)carbamoyl]amino]-5-methoxyphenyl]-4-hydroxybenzamide Chemical compound C=1C(C(C)(C)C)=C(O)C(C(C)(C)C)=CC=1C(=O)NC1=CC(OC)=CC=C1NC(=O)N(CC=1C(=CC(F)=CC=1)F)CC1=CC=CC=N1 PNKMZHKBCSIKMR-UHFFFAOYSA-N 0.000 description 1
- JDVPBASIYKWDPR-UHFFFAOYSA-N 3,5-ditert-butyl-n-[2-[[heptyl(methyl)carbamoyl]amino]-5-methoxyphenyl]-4-hydroxybenzamide Chemical compound CCCCCCCN(C)C(=O)NC1=CC=C(OC)C=C1NC(=O)C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 JDVPBASIYKWDPR-UHFFFAOYSA-N 0.000 description 1
- ZLZGJUKRKPKSFW-UHFFFAOYSA-N 3,5-ditert-butyl-n-[4,5-dichloro-2-[[heptyl(methyl)carbamoyl]amino]phenyl]-4-hydroxybenzamide Chemical compound CCCCCCCN(C)C(=O)NC1=CC(Cl)=C(Cl)C=C1NC(=O)C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 ZLZGJUKRKPKSFW-UHFFFAOYSA-N 0.000 description 1
- SEEZYFXPSSHECA-UHFFFAOYSA-N 3,9-dimethyl-3,9-diazabicyclo[3.3.1]nonan-7-amine Chemical compound C1C(N)CC2CN(C)CC1N2C SEEZYFXPSSHECA-UHFFFAOYSA-N 0.000 description 1
- RNJUOHDFRNDQQV-UHFFFAOYSA-N 3-(4-fluoro-2-nitrophenyl)-1-heptyl-1-methylurea Chemical compound CCCCCCCN(C)C(=O)NC1=CC=C(F)C=C1[N+]([O-])=O RNJUOHDFRNDQQV-UHFFFAOYSA-N 0.000 description 1
- 125000003852 3-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(Cl)=C1[H])C([H])([H])* 0.000 description 1
- BPYHGTCRXDWOIQ-UHFFFAOYSA-N 3-nitropyridin-2-amine Chemical compound NC1=NC=CC=C1[N+]([O-])=O BPYHGTCRXDWOIQ-UHFFFAOYSA-N 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HQGSMOOSZBPPGH-UHFFFAOYSA-N 4-(3-bromopropyl)-2,6-ditert-butylphenol Chemical compound CC(C)(C)C1=CC(CCCBr)=CC(C(C)(C)C)=C1O HQGSMOOSZBPPGH-UHFFFAOYSA-N 0.000 description 1
- DHXBIAQABGFUOW-UHFFFAOYSA-N 4-[3-(2-aminophenoxy)propyl]-2,6-ditert-butylphenol Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CCCOC=2C(=CC=CC=2)N)=C1 DHXBIAQABGFUOW-UHFFFAOYSA-N 0.000 description 1
- SJMJMGVFFRSXOG-UHFFFAOYSA-N 4-benzylpiperazin-1-amine Chemical compound C1CN(N)CCN1CC1=CC=CC=C1 SJMJMGVFFRSXOG-UHFFFAOYSA-N 0.000 description 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 1
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- OFZNQARQYAPFII-HEHNFIMWSA-N 4-n-[(2-aminophenyl)methyl]-4-n-[(2e)-3,7-dimethylocta-2,6-dienyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=CC(N(C)C)=CC=C1N(C\C=C(/C)CCC=C(C)C)CC1=CC=CC=C1N OFZNQARQYAPFII-HEHNFIMWSA-N 0.000 description 1
- CTWCBQNPQZYSQT-HEHNFIMWSA-N 4-n-[(2e)-3,7-dimethylocta-2,6-dienyl]-1-n,1-n-dimethyl-4-n-[(2-nitrophenyl)methyl]benzene-1,4-diamine Chemical compound C1=CC(N(C)C)=CC=C1N(C\C=C(/C)CCC=C(C)C)CC1=CC=CC=C1[N+]([O-])=O CTWCBQNPQZYSQT-HEHNFIMWSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- WJYIASZWHGOTOU-UHFFFAOYSA-N Heptylamine Chemical compound CCCCCCCN WJYIASZWHGOTOU-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- BZORFPDSXLZWJF-UHFFFAOYSA-N N,N-dimethyl-1,4-phenylenediamine Chemical compound CN(C)C1=CC=C(N)C=C1 BZORFPDSXLZWJF-UHFFFAOYSA-N 0.000 description 1
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 102000001494 Sterol O-Acyltransferase Human genes 0.000 description 1
- 108010054082 Sterol O-acyltransferase Proteins 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241001648319 Toronia toru Species 0.000 description 1
- OAXYPWBMCQPISA-UHFFFAOYSA-N [2-(heptylcarbamoylamino)phenyl] 3,5-ditert-butyl-4-hydroxybenzoate Chemical compound CCCCCCCNC(=O)NC1=CC=CC=C1OC(=O)C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 OAXYPWBMCQPISA-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- OYTKINVCDFNREN-UHFFFAOYSA-N amifampridine Chemical compound NC1=CC=NC=C1N OYTKINVCDFNREN-UHFFFAOYSA-N 0.000 description 1
- 229960004012 amifampridine Drugs 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000004210 ether based solvent Substances 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000623 heterocyclic group Chemical class 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000005453 ketone based solvent Substances 0.000 description 1
- 229940041476 lactose 100 mg Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 210000001853 liver microsome Anatomy 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- VCLOGZLTBQMDML-UHFFFAOYSA-N n-(pyridin-2-ylmethyl)cycloheptanamine Chemical compound C=1C=CC=NC=1CNC1CCCCCC1 VCLOGZLTBQMDML-UHFFFAOYSA-N 0.000 description 1
- CBKHIVDMPXDCGZ-UHFFFAOYSA-N n-[2-(1-adamantylcarbamoylamino)-4,5-dichlorophenyl]-3,5-ditert-butyl-4-hydroxybenzamide Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(C(=O)NC=2C(=CC(Cl)=C(Cl)C=2)NC(=O)NC23CC4CC(CC(C4)C2)C3)=C1 CBKHIVDMPXDCGZ-UHFFFAOYSA-N 0.000 description 1
- OTARZURAFWSRJZ-UHFFFAOYSA-N n-[2-(1-adamantylcarbamoylamino)pyridin-3-yl]-3,5-ditert-butyl-4-hydroxybenzamide Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(C(=O)NC=2C(=NC=CC=2)NC(=O)NC23CC4CC(CC(C4)C2)C3)=C1 OTARZURAFWSRJZ-UHFFFAOYSA-N 0.000 description 1
- GXRJHGQEHVGEAH-UHFFFAOYSA-N n-[2-[(1-benzylpiperidin-4-yl)carbamoylamino]-5-methoxyphenyl]-3,5-ditert-butyl-4-hydroxybenzamide Chemical compound C=1C(C(C)(C)C)=C(O)C(C(C)(C)C)=CC=1C(=O)NC1=CC(OC)=CC=C1NC(=O)NC(CC1)CCN1CC1=CC=CC=C1 GXRJHGQEHVGEAH-UHFFFAOYSA-N 0.000 description 1
- DKZIEKWWYJDNCD-UHFFFAOYSA-N n-[2-[[benzyl(cycloheptyl)carbamoyl]amino]-5-methoxyphenyl]-3,5-ditert-butyl-4-hydroxybenzamide Chemical compound C=1C(C(C)(C)C)=C(O)C(C(C)(C)C)=CC=1C(=O)NC1=CC(OC)=CC=C1NC(=O)N(C1CCCCCC1)CC1=CC=CC=C1 DKZIEKWWYJDNCD-UHFFFAOYSA-N 0.000 description 1
- KLALQKBUFIKUIE-UHFFFAOYSA-N n-[2-[[benzyl(pyridin-2-ylmethyl)carbamoyl]amino]-5-methoxyphenyl]-3,5-ditert-butyl-4-hydroxybenzamide Chemical compound C=1C(C(C)(C)C)=C(O)C(C(C)(C)C)=CC=1C(=O)NC1=CC(OC)=CC=C1NC(=O)N(CC=1N=CC=CC=1)CC1=CC=CC=C1 KLALQKBUFIKUIE-UHFFFAOYSA-N 0.000 description 1
- WXQBGGJKSTXMPB-UHFFFAOYSA-N n-[2-[[benzyl(pyridin-2-ylmethyl)carbamoyl]amino]-5-methoxyphenyl]-3,5-ditert-butyl-4-hydroxybenzamide;hydrochloride Chemical compound Cl.C=1C(C(C)(C)C)=C(O)C(C(C)(C)C)=CC=1C(=O)NC1=CC(OC)=CC=C1NC(=O)N(CC=1N=CC=CC=1)CC1=CC=CC=C1 WXQBGGJKSTXMPB-UHFFFAOYSA-N 0.000 description 1
- LVYVLQJXGIJMEN-UHFFFAOYSA-N n-[4-(dimethylamino)phenyl]-2-(heptylcarbamoylamino)benzamide;hydrochloride Chemical compound Cl.CCCCCCCNC(=O)NC1=CC=CC=C1C(=O)NC1=CC=C(N(C)C)C=C1 LVYVLQJXGIJMEN-UHFFFAOYSA-N 0.000 description 1
- KARSJEQFQOBUHO-UHFFFAOYSA-N n-benzylcycloheptanamine Chemical compound C=1C=CC=CC=1CNC1CCCCCC1 KARSJEQFQOBUHO-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- XDUHQPOXLUAVEE-ZDRVVMPWSA-N s-[2-[3-[[(2r)-4-[[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (z)-octadec-9-enethioate Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS[14C](=O)CCCCCCC\C=C/CCCCCCCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 XDUHQPOXLUAVEE-ZDRVVMPWSA-N 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000759 toxicological effect Toxicity 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000003738 xylenes Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
- C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2756094 | 1994-02-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69407561D1 DE69407561D1 (de) | 1998-02-05 |
| DE69407561T2 true DE69407561T2 (de) | 1998-07-30 |
Family
ID=12224434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69407561T Expired - Fee Related DE69407561T2 (de) | 1994-02-01 | 1994-10-10 | Harnstoff Derivate und deren Verwendung als ACAT Inhibitoren |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US5576335A (https=) |
| EP (1) | EP0665216B1 (https=) |
| KR (1) | KR950025025A (https=) |
| CA (1) | CA2133394A1 (https=) |
| DE (1) | DE69407561T2 (https=) |
| TW (1) | TW259788B (https=) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9514160D0 (en) * | 1994-07-25 | 1995-09-13 | Zeneca Ltd | Aromatic compounds |
| CA2197364A1 (en) * | 1996-02-15 | 1997-08-16 | Toshikazu Suzuki | Phenol compound and process for preparing the same |
| US6271261B1 (en) * | 1996-06-27 | 2001-08-07 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| SK282727B6 (sk) | 1997-12-19 | 2002-11-06 | Slovakofarma, A. S. | 1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy |
| JP2003508512A (ja) | 1999-09-08 | 2003-03-04 | ギルフォード ファーマシュウティカルズ インコーポレイテッド | 非ペプチド性サイクロフィリン結合化合物とその用途 |
| WO2002055484A1 (en) * | 2001-01-12 | 2002-07-18 | Takeda Chemical Industries, Ltd. | Biaryl compound, process for producing the same, and agent |
| US6656971B2 (en) | 2001-01-25 | 2003-12-02 | Guilford Pharmaceuticals Inc. | Trisubstituted carbocyclic cyclophilin binding compounds and their use |
| FR2821356A1 (fr) * | 2001-02-23 | 2002-08-30 | Cerep | Nouveaux derives d'arylcarbamates et d'arylurees, preparations et utilisations |
| JPWO2003091216A1 (ja) * | 2002-04-25 | 2005-09-02 | 住友製薬株式会社 | 新規ピペリジン誘導体 |
| TW200418812A (en) * | 2002-10-29 | 2004-10-01 | Smithkline Beecham Corp | IL-8 receptor antagonists |
| US20050026844A1 (en) * | 2003-04-03 | 2005-02-03 | Regents Of The University Of California | Inhibitors for the soluble epoxide hydrolase |
| WO2005089380A2 (en) | 2004-03-16 | 2005-09-29 | The Regents Of The University Of California | Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids |
| EP2927693A1 (en) | 2004-10-06 | 2015-10-07 | The Brigham and Women's Hospital | Relevance of achieved levels of markers of systemic inflammation following treatment |
| JP2008517072A (ja) * | 2004-10-20 | 2008-05-22 | ザ レジェンツ オブ ザ ユニバーシティー オブ カリフォルニア | 可溶性エポキシド加水分解酵素の改良された阻害剤 |
| PL2009992T3 (pl) * | 2006-04-21 | 2012-11-30 | Glaxosmithkline Llc | Antagoniści receptora IL-8 |
| US8097626B2 (en) * | 2006-04-21 | 2012-01-17 | Glaxosmithkline Llc | IL-8 receptor antagonists |
| CL2007001829A1 (es) * | 2006-06-23 | 2008-01-25 | Smithkline Beecham Corp | P-toluensulfonato de n-[4-cloro-2-hidroxi-3-(piperazina-1-sulfonil)fenil]-n-(2-cloro-3-fluorofenil)urea;procedimiento de preparacion;composicion farmaceutica;combinacion farmaceutica;y uso en el tratamiento de una enfermedad mediada por la quiimioquina il-8, tales como asma y epoc. |
| US8022217B2 (en) * | 2006-07-31 | 2011-09-20 | Cadila Healthcare Limited | Compounds suitable as modulators of HDL |
| US20110039893A1 (en) * | 2006-10-11 | 2011-02-17 | Takeda Pharmaceutical Company Limited | Gsk-3beta inhibitor |
| HRP20090186A2 (hr) | 2009-03-31 | 2010-10-31 | Institut Ruđer Bošković | Adamantanski bisureidni derivati, metoda priprave i primjena u detekciji aniona |
| UY36547A (es) | 2015-02-05 | 2016-06-01 | Bayer Cropscience Ag | Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas |
| UY36548A (es) | 2015-02-05 | 2016-06-01 | Bayer Cropscience Ag | Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas |
| CN107810188B (zh) | 2015-04-08 | 2020-09-22 | 拜耳作物科学股份公司 | 作为害虫防治剂和中间体产物的稠合双环杂环衍生物 |
| TW201718514A (zh) | 2015-08-07 | 2017-06-01 | 拜耳作物科學股份有限公司 | 作為殺蟲劑之經２－（雜）芳基取代之稠合雜環衍生物 |
| PE20181198A1 (es) | 2015-10-26 | 2018-07-23 | Bayer Cropscience Ag | Derivados de heterociclos biciclicos condensados como agentes de control de plagas |
| WO2017093180A1 (de) | 2015-12-01 | 2017-06-08 | Bayer Cropscience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
| WO2017144341A1 (de) | 2016-02-23 | 2017-08-31 | Bayer Cropscience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
| WO2017174414A1 (de) | 2016-04-05 | 2017-10-12 | Bayer Cropscience Aktiengesellschaft | Naphthalin-derivate als schädlingsbekämpfungsmittel |
| EP3241830A1 (de) | 2016-05-04 | 2017-11-08 | Bayer CropScience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
| RU2019104378A (ru) | 2016-07-19 | 2020-08-19 | Байер Кропсайенс Акциенгезельшафт | Конденсированные бициклические гетероциклические производные в качестве средств для борьбы с вредителями |
| MX2019001918A (es) | 2016-08-15 | 2019-09-06 | Bayer Cropscience Ag | Derivados del heterociclo biciclico condensado como agentes de control de plagas. |
| WO2018050825A1 (de) | 2016-09-19 | 2018-03-22 | Bayer Cropscience Aktiengesellschaft | Pyrazolo[1,5-a]pyridin- derivative und ihre verwendung als schädlingsbekämpfungsmittel |
| JP6994504B2 (ja) | 2016-10-06 | 2022-01-14 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | 有害生物防除剤としての２－（ヘタ）アリール置換された縮合二環式複素環誘導体 |
| WO2018138050A1 (de) | 2017-01-26 | 2018-08-02 | Bayer Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
| TW201833107A (zh) | 2017-02-06 | 2018-09-16 | 德商拜耳廠股份有限公司 | 作為殺蟲劑之經２－（雜）芳基取代的稠合雜環衍生物 |
| KR102537983B1 (ko) | 2017-04-24 | 2023-05-31 | 바이엘 악티엔게젤샤프트 | 해충 방제제로서의 축합된 비시클릭 헤테로시클릭-화합물 유도체 |
| EP3305786A3 (de) | 2018-01-22 | 2018-07-25 | Bayer CropScience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
| US11019821B2 (en) | 2018-02-21 | 2021-06-01 | Bayer Aktiengesellschaft | Fused bicyclic heterocycle derivatives as pesticides |
| BR112021003665A2 (pt) | 2018-09-13 | 2021-05-18 | Bayer Aktiengesellschaft | derivados de heterocicleno como agentes de controle de pragas |
| PY2011993A (es) | 2019-02-26 | 2021-07-05 | Bayer Ag | Derivados heterocíclos bicíclicos condensados como plaguicida |
| PY2012000A (es) | 2019-02-26 | 2023-07-25 | Bayer Ag | Derivados de heterociclos bicíclicos fusionados como pesticidas |
| US20230212163A1 (en) | 2020-04-21 | 2023-07-06 | Bayer Aktiengesellschaft | 2-(het)aryl-substituted condensed heterocyclic derivatives as pest control agents |
| EP4337661A1 (de) | 2021-05-12 | 2024-03-20 | Bayer Aktiengesellschaft | 2-(het)aryl-substituierte kondensierte heterocyclen-derivate als schädlingsbekämpfungsmittel |
| EP4368612A4 (en) * | 2021-06-30 | 2025-11-05 | Samsung Display Co Ltd | Novel connection for top layer and organic light-emitting device so that |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3660486A (en) * | 1969-12-15 | 1972-05-02 | Degussa | Diphenyl amine urea derivatives |
| US5116848A (en) * | 1988-03-30 | 1992-05-26 | Warner-Lambert Company | N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents |
| DE3822448A1 (de) * | 1988-07-02 | 1990-03-01 | Bayer Ag | Ureido-benzoesaeure-derivate |
| GB8827152D0 (en) * | 1988-11-21 | 1988-12-29 | Wellcome Found | Anti-atherosclerotic diaryl compounds |
| US5258405A (en) * | 1990-03-12 | 1993-11-02 | Yamanouchi Pharmaceutical Co., Ltd. | Urea derivatives and salts thereof in method for inhibiting the ACAT enzyme |
| US5668136A (en) * | 1990-09-25 | 1997-09-16 | Eisai Co., Ltd. | Trisubstituted benzene derivatives, composition and methods of treatment |
| US5214206A (en) * | 1990-11-07 | 1993-05-25 | Warner-Lambert Company | Aminosulfonyl urea acat inhibitors |
-
1994
- 1994-09-29 US US08/314,814 patent/US5576335A/en not_active Expired - Fee Related
- 1994-09-30 CA CA002133394A patent/CA2133394A1/en not_active Abandoned
- 1994-10-07 TW TW083109319A patent/TW259788B/zh active
- 1994-10-10 EP EP94307398A patent/EP0665216B1/en not_active Expired - Lifetime
- 1994-10-10 KR KR1019940025817A patent/KR950025025A/ko not_active Withdrawn
- 1994-10-10 DE DE69407561T patent/DE69407561T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5576335A (en) | 1996-11-19 |
| CA2133394A1 (en) | 1995-08-02 |
| DE69407561D1 (de) | 1998-02-05 |
| TW259788B (https=) | 1995-10-11 |
| KR950025025A (ko) | 1995-09-15 |
| EP0665216B1 (en) | 1997-12-29 |
| EP0665216A1 (en) | 1995-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69407561T2 (de) | Harnstoff Derivate und deren Verwendung als ACAT Inhibitoren | |
| DE69404382T2 (de) | Urea-Derivate und ihre Verwendung als ACAT-hemmenden Verbindungen | |
| EP0496378B1 (de) | Biphenylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
| DE69431042T2 (de) | Pyrazol oder isoxazol substituierte alkylamide als acat inhibitoren | |
| DE69432019T2 (de) | Amidin-derivate mit stickstoffoxid-synthease-aktivität | |
| EP0270947B1 (de) | Substituierte basische 2-Aminotetraline | |
| DE69309030T2 (de) | Trisubstituierte phenylderivate als selektive phosphodiesterase iv inhibitoren | |
| DE69524246T2 (de) | 1,2,3,4-Tetrahydroquinoxalindion Derivate und ihre Verwendung als Glutamat Rezeptor Antagonisten | |
| EP0505868B1 (de) | N-Acyl-alpha-aminosäurederivate | |
| DE69002996T2 (de) | Triphenylmethan-Derivate. | |
| DE60033689T2 (de) | Inhibitoren von serinproteasen | |
| DE69734773T2 (de) | Nicht-peptidische Bombesin-Rezeptor-Antagonisten | |
| DE4234295A1 (de) | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
| DE19943636A1 (de) | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften | |
| EP0537696A1 (de) | Heterobiarylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
| DE19636689A1 (de) | Neue Benzamidinderivate | |
| DE10128331A1 (de) | Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen | |
| EP0574808A1 (de) | Amidin-Biphenylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
| EP1286957B1 (de) | Diphenylmethanderivate | |
| EP1891004A1 (de) | Pentafluorsulfanyl-substituierte verbindung und deren verwendung zur herstellung von arzneimitteln | |
| DE69818516T2 (de) | Phenylaminoalkylcarbonsäure-derivate und medizinische zusammensetzungen, die diese enthalten | |
| EP1572628B1 (de) | Isophthalsäurederivate | |
| DE3850603T2 (de) | Arylaralkylether, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung. | |
| EP0719763A1 (de) | 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate mit antiatherosklerotischer Wirkung | |
| WO2001047899A1 (de) | Substituierte piperazinderivateals inhibitoren des mtp |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: NISSHIN SEIFUN GROUP INC., TOKIO/TOKYO, JP |
|
| 8339 | Ceased/non-payment of the annual fee |